
Sign up to save your podcasts
Or


Of all the things women worry about when it comes to hormone therapy, breast cancer, for many, tops the list. Our current understanding of breast cancer risk–even among at-risk women–has changed dramatically in recent years and continues to evolve. To fully understand hormone therapy and breast cancer risk, we need to understand that hormone therapy is not all the same, nor is breast cancer. There are many forms and formulations of hormone therapy and there are many variations of the disease we call breast cancer. This week we break it all down with the Director of the Gynecology Center for Cancer Survivors and At-Risk Women at UCSF, Dr. Mindy Goldman, who wants all women to know, no matter their situation, they do not have to suffer with menopausal symptoms.
Mindy Goldman, MD, is Chief Clinical Officer & Clinical Professor Emeritus at UCSF. For almost three decades, Dr. Goldman has been a Clinical Professor in the Department of OB/GYN at UCSF, where she is also the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she is a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She has helped author guidelines in these areas for the American College of Obstetrics and Gynecology (ACOG). She is on the survivorship panel for the National Comprehensive Cancer Network (NCCN) where she is the Chair of the menopause panel and the Co-Chair of the sexual functioning panel, which provide guidelines in these topic areas for practicing oncologists. Throughout her career, Dr. Goldman has received numerous recognitions, including: San Francisco Magazine: Top Doctors (2015-2022), America's Top Doctors for Cancer (7th-10th Edition) and Exceptional Women In Medicine (2019-2021). You can learn more about her and her work at Dr. Mindy Goldman.
Sign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/
Learn More and Register for our 2026 Tucson Bike Camp: https://feisty.co/events/gravel-camp-x-bike-mechanic-school/
Join the Feisty Strong Barbell Club: https://feisty.co/strong-club/ and use code: STRONG2026 to save $50
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
Support our Partners:
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Cozy Earth: Use Code HITPLAY at https://cozyearth.com/ for up to 20% off
Hettas: Use code STAYFEISTY for 20% off at https://hettas.com/
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
By Hit Play Not Pause4.9
699699 ratings
Of all the things women worry about when it comes to hormone therapy, breast cancer, for many, tops the list. Our current understanding of breast cancer risk–even among at-risk women–has changed dramatically in recent years and continues to evolve. To fully understand hormone therapy and breast cancer risk, we need to understand that hormone therapy is not all the same, nor is breast cancer. There are many forms and formulations of hormone therapy and there are many variations of the disease we call breast cancer. This week we break it all down with the Director of the Gynecology Center for Cancer Survivors and At-Risk Women at UCSF, Dr. Mindy Goldman, who wants all women to know, no matter their situation, they do not have to suffer with menopausal symptoms.
Mindy Goldman, MD, is Chief Clinical Officer & Clinical Professor Emeritus at UCSF. For almost three decades, Dr. Goldman has been a Clinical Professor in the Department of OB/GYN at UCSF, where she is also the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she is a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She has helped author guidelines in these areas for the American College of Obstetrics and Gynecology (ACOG). She is on the survivorship panel for the National Comprehensive Cancer Network (NCCN) where she is the Chair of the menopause panel and the Co-Chair of the sexual functioning panel, which provide guidelines in these topic areas for practicing oncologists. Throughout her career, Dr. Goldman has received numerous recognitions, including: San Francisco Magazine: Top Doctors (2015-2022), America's Top Doctors for Cancer (7th-10th Edition) and Exceptional Women In Medicine (2019-2021). You can learn more about her and her work at Dr. Mindy Goldman.
Sign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/
Learn More and Register for our 2026 Tucson Bike Camp: https://feisty.co/events/gravel-camp-x-bike-mechanic-school/
Join the Feisty Strong Barbell Club: https://feisty.co/strong-club/ and use code: STRONG2026 to save $50
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
Support our Partners:
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Cozy Earth: Use Code HITPLAY at https://cozyearth.com/ for up to 20% off
Hettas: Use code STAYFEISTY for 20% off at https://hettas.com/
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/

1,073 Listeners

186 Listeners

2,042 Listeners

191 Listeners

69 Listeners

2,636 Listeners

8,555 Listeners

331 Listeners

130 Listeners

603 Listeners

1,107 Listeners

78 Listeners
![[un]phased podcast by [un]phased podcast](https://podcast-api-images.s3.amazonaws.com/corona/show/1550501/logo_300x300.jpeg)
19 Listeners

118 Listeners

29 Listeners

413 Listeners

371 Listeners

1,187 Listeners

213 Listeners

90 Listeners

5 Listeners

47 Listeners